US Labs is a leading provider of cancer diagnostic and genetics testing services. The company provides diagnostic and prognostic cancer testing to pathologists, oncologists, and urologists throughout the United States. Services are marketed through a national sales force and supported by regional courier networks. All testing is performed in a state of the art laboratory located in Irvine, California. The company offers its diagnostic testing services in the anatomic pathology and molecular diagnostics markets. The major market segments include immunohistochemistry, flow cytometry, cytogenetics and fluorescence in situ hybridization. US Labs is the leading provider of FISH and Image testing services in the U.S.
The company’s strategy is to leverage its anatomic pathology with the advances in genetic testing and new technologies into the commercialization of new diagnostic tests.
US Labs and De Novo Software collaborate to create innovative solutions for flow cytometry data analysis in a high-throughput setting.